Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Corona Virus Infection: full-pipeline trial registry
8 of 29 indexed Corona Virus Infection trials are currently recruiting.
Corpus placement: #552 of 28,707 conditions by registered trial count.
29 US clinical trials · 8 currently recruiting · #552 of 28,707 conditions by registered trial count
Corona Virus Infection: 29 US clinical trials tracked, 8 recruiting.
Corona Virus Infection is the subject of 29 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 3 of these trials.
Enrollment posture brief
Registry condition corona-virus-infection
OPEN 8 | RECR 28% | LATE 3 | EARLY 4 | RANK #552 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Health Knowledge, Attitudes, Practice (28% recruiting · 29 trials)
Corona Virus Infection lists 8 open slots (28% of 29 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Corona Virus Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Corona Virus Infection is recruiting below its size-band peers.
8 of 29 indexed trials (27.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Corona Virus Infection trials is spread across many organizations.
Columbia University accounts for 3 of 29 trials (10.3%). 25 distinct sponsors appear on at least one study for this condition label.
-
Typical Corona Virus Infection enrolment sits around 155 participants.
Median target enrolment is 155 among the 29 trials that report a genuine target (sentinel values excluded). 10 of those (34.5%) plan for fewer than 100 participants.
-
Corona Virus Infection splits between interventional and observational designs.
14 interventional and 15 observational studies make up this index (48.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
29 total, page 1 of 1
KIDney Injury in Times of COVID-19 (KIDCOV)
University of California, San Francisco
NCT04705766
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Columbia University
NCT04367857
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Columbia University
NCT04448145
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
St. Jude Children's Research Hospital
NCT04371315
A Study to Explore the Role of Gut Flora in COVID-19 Infection
ProgenaBiome
NCT04359836
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
West Virginia University
NCT04376034
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Stanford University
NCT04579588
Post COVID-19 Biorepository
University of Kansas Medical Center
NCT04885504
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
University of California, San Francisco
NCT04388605
Long Term Outcomes of Patients With COVID-19
University of Chicago
NCT04360538
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
The Geneva Foundation
NCT05765396
Community Collaboration to Combat COVID-19 (C-FORWARD)
Johns Hopkins University
NCT04673292
University of Utah COVID-19 Hydrochloroquine Trial
University of Utah
NCT04342169
A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit
Lucira Health
NCT04720235
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS
Rush University Medical Center
NCT04325906
Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)
University of Washington
NCT05074719
Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
University of Minnesota
NCT04339998
Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
University of Michigan
NCT05212610
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
Lucira Health
NCT04720794
WGS Analysis of COVID-19 Positive Patients
Vanda Pharmaceuticals
NCT04353401
COVID-19 and Lactating Mothers
University of Rochester
NCT04558320
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Apellis Pharmaceuticals
NCT04402060
COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications
James L. Kirkland, MD, PhD
NCT04771611
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
Cytokind
NCT04818970
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
University of Virginia
NCT04374565
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
Columbia University
NCT04408222
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment
University of Oklahoma
NCT04416919
Computer Cognitive Training for Post-acute COVID-19 Syndrome
Nova Southeastern University
NCT05338749
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
St. Francis Hospital, New York
NCT04621461
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Corona Virus Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Corona Virus Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Corona Virus Infection page
29 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Corona Virus Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Columbia University sponsors the most Corona Virus Infection trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Corona Virus Infection condition card totals 29 registered trials; most-linked intervention Lucira COVID-19 All-In-One test kit; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.